EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The Effect of Polyphenol Supplementation in People with Multiple Sclerosis: A Systematic Review of Clinical Trials

Lauren Brooks, Aqif Farhan Bin Azmil Farid iD, Amudha Poobalan, Alexandra Johnstone iD, Phyo Kyaw Myint iD

Nutrients · 10.06.2026 · 18 (12) · 1875

DOI: 10.3390/nu18121875 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 10.06.2026. Verfasst von Lauren Brooks und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK. Hauptthemen laut MEDLINE: Multiple Sclerosis, Polyphenols, Dietary Supplements. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Multiple sclerosis (MS) is an autoimmune neuroinflammatory disease affecting 2.9 million worldwide. Current immunosuppressive treatments offer limited neuroprotection and often cause adverse effects. Polyphenols with antioxidant and anti-inflammatory properties have been investigated as adjuncts in MS.

Methods

On 19 June 2025, Embase, Medline, and ClinicalTrials.gov were systematically searched. Eligible clinical trials assessing polyphenol supplementation in MS were included. Outcomes of interest were Expanded Disability Status Scale (EDSS), annualised relapse rate (ARR), magnetic resonance imaging (MRI) changes, safety, and tolerability. Risk of bias was evaluated using the Cochrane tool, and certainty of evidence was appraised with Grading of Recommendations Assessment, Development, and Evaluation (GRADE). The protocol was registered with PROSPERO (CRD420251052042).

Results

Of 870 records identified, 13 trials (n = 785) met inclusion. Nanocurcumin consistently improved EDSS in relapsing–remitting MS (3 trials, n = 150; p = 0.039–0.041), while epigallocatechin-3-gallate, silymarin (SM), cranberry extract, and bio-enhanced curcumin extract (BCM-95) curcumin showed no significant impact on disability, relapse rates, or MRI outcomes. Intervention adverse events were generally mild. SM showed potential hepatoprotective effects. Risk of bias was determined as low risk for seven of the trials and of some concern for five of the studies. Most often raising concerns because of selective reporting. Certainty of evidence, assessed using GRADE, was generally moderate, indicating some uncertainty regarding the outcomes. Meta-analysis was not possible due to the heterogeneity of included studies.

Conclusions

Nanocurcumin may contribute to improvements in disability outcomes in Relapse Remitting Multiple Sclerosis (RRMS), whereas other polyphenols lack consistent efficacy. However, the evidence base remains limited by small sample sizes and methodological concerns. Larger, multicentre randomised controlled trials are required to establish optimal dosing, long-term safety, and therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisPolyphenolsDietary SupplementsHumansCurcuminAntioxidantsClinical Trials as TopicCatechinSilymarinPlant ExtractsVaccinium macrocarponFemaleMaleAnti-Inflammatory Agents

Stichwörter der Autor:innen

cognitioncurcumindepressiondietary supplementsfatigueflavanolsinflammationmultiple sclerosisphenolic acidspolyphenolssystematic review

Substanzen

PolyphenolsCurcuminAntioxidantsCatechinSilymarinPlant Extractsepigallocatechin gallateAnti-Inflammatory Agents

Autor:innen und Institutionen

  • School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen AB25 2ZD, UK.
  • North Bristol NHS Trust, Southmead Hospital, Bristol BS10 5NB, UK.
  • Aberdeen Royal Infirmary, Aberdeen AB25 2ZN, UK.
  • The Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, Foresterhill Campus, University of Aberdeen, Aberdeen AB25 2ZD, UK.
  • The Rowett Institute, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Foresterhill Health Campus, Ashgrove Road West, Aberdeen AB25 2ZD, UK.

ORCID-Profile: Aqif Farhan Bin Azmil Farid, Alexandra Johnstone, Phyo Kyaw Myint

Zitieren

APA

Brooks, L., Farid, A. F. B. A., Poobalan, A., Johnstone, A., & Myint, P. K. (2026). The Effect of Polyphenol Supplementation in People with Multiple Sclerosis: A Systematic Review of Clinical Trials. Nutrients, 18(12), 1875. https://doi.org/10.3390/nu18121875

Vancouver

Brooks L, Farid AFBA, Poobalan A, Johnstone A, Myint PK. The Effect of Polyphenol Supplementation in People with Multiple Sclerosis: A Systematic Review of Clinical Trials. Nutrients. 2026;18(12):1875. doi:10.3390/nu18121875

BibTeX
@article{Brooks2026,
  author = {Brooks, Lauren and Farid, Aqif Farhan Bin Azmil and Poobalan, Amudha and Johnstone, Alexandra and Myint, Phyo Kyaw},
  title = {The Effect of Polyphenol Supplementation in People with Multiple Sclerosis: A Systematic Review of Clinical Trials},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {12},
  pages = {1875},
  doi = {10.3390/nu18121875}
}
Kostenlos starten →